Appraising Harm in Phase I Trials: Healthy Volunteers’ Accounts of Adverse Events
July 17, 2019
While risk of harm is an important focus for whether clinical research on humans can and should proceed, there is uncertainty about what constitutes harm to a trial participant. In Phase I trials on healthy volunteers, the purpose of the research is to document and measure safety concerns associated with...